Search Results - "Friedrich, Lawrence V." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an In Vitro Infection Model

by VANSCOY, Brian, MENDES, Rodrigo E, STEENBERGEN, Judith N, AMBROSE, Paul G, NICASIO, Anthony M, CASTANHEIRA, Mariana, BULIK, Catharine C, OKUSANYA, Olanrewaju O, BHAVNANI, Sujata M, FORREST, Alan, JONES, Ronald N, FRIEDRICH, Lawrence V
Published in Antimicrobial Agents and Chemotherapy (01.06.2013)

Get full text

Journal Article

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

by VANSCOY, Brian, MENDES, Rodrigo E, AMBROSE, Paul G, MCCAULEY, Jennifer, BHAVNANI, Sujata M, BULIK, Catharine C, OKUSANYA, Olanrewaju O, FORREST, Alan, JONES, Ronald N, FRIEDRICH, Lawrence V, STEENBERGEN, Judith N
Published in Antimicrobial Agents and Chemotherapy (01.12.2013)

Get full text

Journal Article

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

by Lamp, Kenneth C., PharmD, Friedrich, Lawrence V., PharmD, Mendez-Vigo, Luke, PharmD, Russo, Rene, PharmD
Published in The American journal of medicine (01.10.2007)

Get full text

Journal Article

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

Relationship between Ceftolozane-Tazobactam Exposure and Drug Resistance Amplification in a Hollow-Fiber Infection Model

by VANSCOY, Brian, MENDES, Rodrigo E, AMBROSE, Paul G, CASTANHEIRA, Mariana, MCCAULEY, Jennifer, BHAVNANI, Sujata M, FORREST, Alan, JONES, Ronald N, OKUSANYA, Olanrewaju O, FRIEDRICH, Lawrence V, STEENBERGEN, Judith
Published in Antimicrobial Agents and Chemotherapy (01.09.2013)

Get full text

Journal Article

Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience

Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: A retrospective cohort study utilizing the Cubicin® Outcomes Registry and Experience

by Sakoulas, George, MD, Brown, Jack, PharmD, Lamp, Kenneth C., PharmD, Friedrich, Lawrence V., PharmD, Lindfield, Kimberly C., PhD
Published in Clinical therapeutics (01.09.2009)

Get full text

Journal Article

Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin

Postmarketing Clinical Experience in Patients with Skin and Skin-Structure Infections Treated with Daptomycin

by Owens, Robert C., PharmD, Lamp, Kenneth C., PharmD, Friedrich, Lawrence V., PharmD, Russo, Rene, PharmD
Published in The American journal of medicine (01.10.2007)

Get full text

Journal Article

Cubicin Outcomes Registry and Experience (CORE) Methodology

Cubicin Outcomes Registry and Experience (CORE) Methodology

by Rolston, Kenneth V.I., MD, Segreti, John, MD, Lamp, Kenneth C., PharmD, Friedrich, Lawrence V., PharmD
Published in The American journal of medicine (01.10.2007)

Get full text

Journal Article

Daptomycin in the Treatment of Bacteremia

Daptomycin in the Treatment of Bacteremia

by Sakoulas, George, MD, Golan, Yoav, MD, MS, Lamp, Kenneth C., PharmD, Friedrich, Lawrence V., PharmD, Russo, Rene, PharmD
Published in The American journal of medicine (01.10.2007)

Get full text

Journal Article

Comparison of methods of interpretation of checkerboard synergy testing

Comparison of methods of interpretation of checkerboard synergy testing

by Bonapace, Charles R., Bosso, John A., Friedrich, Lawrence V., White, Roger L.
Published in Diagnostic microbiology and infectious disease (01.12.2002)

Get full text

Journal Article

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model

by Nicasio, Anthony M, VanScoy, Brian D, Mendes, Rodrigo E, Castanheira, Mariana, Bulik, Catharine C, Okusanya, Olanrewaju O, Bhavnani, Sujata M, Forrest, Alan, Jones, Ronald N, Friedrich, Lawrence V, Steenbergen, Judith N, Ambrose, Paul G
Published in Antimicrobial agents and chemotherapy (01.04.2016)

Get full text

Journal Article

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model

by VanScoy, Brian D, Mendes, Rodrigo E, Castanheira, Mariana, McCauley, Jennifer, Bhavnani, Sujata M, Jones, Ronald N, Friedrich, Lawrence V, Steenbergen, Judith N, Ambrose, Paul G
Published in Antimicrobial agents and chemotherapy (01.10.2014)

Get full text

Journal Article

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor

Pharmacokinetics-Pharmacodynamics of CB-618 in Combination with Cefepime, Ceftazidime, Ceftolozane, or Meropenem: the Pharmacological Basis for a Stand-Alone β-Lactamase Inhibitor

by Ambrose, Paul G, VanScoy, Brian D, Trang, Michael, McCauley-Miller, Jennifer, Conde, Haley, Bhavnani, Sujata M, Alexander, Dylan C, Friedrich, Lawrence V
Published in Antimicrobial agents and chemotherapy (01.12.2017)

Get full text

Journal Article

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model

Pharmacokinetics-Pharmacodynamics of a Novel β-Lactamase Inhibitor, CB-618, in Combination with Meropenem in an In Vitro Infection Model

by VanScoy, Brian D, Trang, Michael, McCauley, Jennifer, Conde, Haley, Bhavnani, Sujata M, Friedrich, Lawrence V, Alexander, Dylan C, Ambrose, Paul G
Published in Antimicrobial agents and chemotherapy (01.07.2016)

Get full text

Journal Article

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)

by Mohr, John F, Friedrich, Lawrence V, Yankelev, Sara, Lamp, Kenneth C
Published in International journal of antimicrobial agents (01.06.2009)

Get full text

Journal Article

Determination of Antibiotic Effect in an In Vitro Pharmacodynamic Model: Comparison with an Established Animal Model of Infection

Determination of Antibiotic Effect in an In Vitro Pharmacodynamic Model: Comparison with an Established Animal Model of Infection

by BONAPACE, Charles R, FRIEDRICH, Lawrence V, BOSSO, John A, WHITE, Roger L
Published in Antimicrobial Agents and Chemotherapy (01.11.2002)

Get full text

Journal Article

Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations

Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations

by Soon, Rachel L, Lenhard, Justin R, Bulman, Zackery P, Holden, Patricia N, Kelchlin, Pamela, Steenbergen, Judith N, Friedrich, Lawrence V, Forrest, Alan, Tsuji, Brian T
Published in Antimicrobial agents and chemotherapy (01.04.2016)

Get full text

Journal Article

In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing escherichia coli in a hollow-fibre infection model

In vitro pharmacodynamic evaluation of ceftolozane/tazobactam against β-lactamase-producing escherichia coli in a hollow-fibre infection model

by Soon, Rachel L, Lenhard, Justin R, Bulman, Zackery P, Holden, Patricia N, Kelchlin, Pamela, Steenbergen, Judith N, Friedrich, Lawrence V, Forrest, Alan, Tsuji, Brian T
Published in International journal of antimicrobial agents (01.01.2017)

Get full text

Journal Article

Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram-Negative Aerobes

Impact of Use of Multiple Antimicrobials on Changes in Susceptibility of Gram-Negative Aerobes

by Friedrich, Lawrence V., White, Roger L., Bosso, John A.
Published in Clinical infectious diseases (01.05.1999)

Get full text

Journal Article

Fatal hypoglycemia associated with levofloxacin

Fatal hypoglycemia associated with levofloxacin

by Friedrich, Lawrence V, Dougherty, Richard
Published in Pharmacotherapy (01.12.2004)

Get more information

Journal Article

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000

Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999–2000

by White, Roger L, Enzweiler, Kevin A, Friedrich, Lawrence V, Wagner, David, Hoban, Daryl, Bosso, John A
Published in Diagnostic microbiology and infectious disease (01.07.2002)

Get full text

Journal Article